Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

FDA grants raloxifene NDA priority review status

July 24, 1997

Genetic and molecular pathogenesis of IDDM

July 24, 1997

Pierre Fabre prepares compounds for hypercholesterolemia/atherosclerosis

July 24, 1997

Hepatic insulin gene expression for treatment of IDDM

July 23, 1997

Diabetes: an epidemic for the 21st century

July 23, 1997

Troglitazone clinical data presented at IDF 97

July 23, 1997

Problems of insulin supply: insulin turns 75

July 23, 1997

FINFAT multicenter trial results reported at IDF 97

July 23, 1997

Recombinant infertility drug launched in Canada

July 23, 1997

Economics of diabetes discussed at IDF 97

July 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...